Sidra Medicine Appoints Dr. Iyabo Tinubu-Karch as Chief Executive Officer 21 December 2022, Doha, Qatar – Sidra Medicine, a QF entity, has announced the appointment of Dr. Iyabo Tinubu-Karch as its Chief Executive Officer. Dr. Tinubu-Karch has extensive clinical experi… Continue Reading.....

Sidra Medicine launches Male Infertility Clinic QF Entity expands reproductive medicine services to provide comprehensive care for couples Sidra Medicine has launched a new male infertility clinic as part of its expansion of private reproductive… Continue Reading.....

Sidra Medicine Diabetes Research to Help Establish National Diabetes Registry in Qatar QF Entity focuses on prevention and disease management in support of World Diabetes Day 13 November 2022, Doha, Qatar – Researchers and clinicians at Sidra Medicine have conducted comprehensive stu… Continue Reading.....

Sidra Medicine first hospital in MENA to implant newly certified artificial heart valve QF Entity participation in clinical trials leads to approval of the Venus P-Valve for worldwide use 08 November 2022, Doha, Qatar – Sidra Medicine has been selected as the first hospital in the Mid… Continue Reading.....

Sidra Medicine Treats Ugandan Patient with Lymphangioma QF Entity cares for over 500 international patients in five years 02 November 2022, Doha, Qatar – Surgeons from Sidra Medicine performed a life-saving procedure on an international patient from Uga… Continue Reading.....

Sidra Medicine signs MoU with Microsoft to achieve digital transformation goals in research 25 October 2022, Doha, Qatar – Sidra Medicine has signed a memorandum of understanding (MoU) with Microsoft to facilitate its research division’s digital transformation goals and accelerate its precis… Continue Reading.....